JEFFERIES FINANCIAL GROUP IN (JEF) Stock Analyst Ratings
USA - NYSE:JEF - US47233W1099 - Common Stock
66.65 USD
-0.53 (-0.79%)
66.65 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 76% to JEF. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 74.46. This target is 11.72% above the current price.
JEF was analyzed by 9 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about JEF.
In the previous month the buy percentage consensus was at a similar level.
JEF was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-08 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-15 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-07 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-03-27 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-19 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2025-03-13 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-01-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-12-09 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-11-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-11-05 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-09-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-17 | UBS | Initiate | Buy |
| 2024-09-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-07-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-06-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-30 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-04-02 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-09-06 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-08-22 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2023-07-12 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-06-28 | Morgan Stanley | Reiterate | Underweight -> Underweight |
| 2023-06-21 | Morgan Stanley | Reiterate | Underweight |
| 2023-06-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-04-12 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2023-04-06 | Oppenheimer | Maintains | Outperform |
| 2023-03-24 | Oppenheimer | Maintains | Outperform |